Condition
Oncologic Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Oncologic Diseases clinical trials that are recruiting, at sites in 4 countries (most in Italy (2), Spain (1), Israel (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Oncologic Diseases clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| NUT Project: Nutritional Support in Thoracic Cancer | — | Peschiera del Garda, Verona | Recruiting | Sep 14, 2026 |
| My Care My Voice: helping patients and clinicians start palliative care conversations | — | Aalst, East-Flanders and 3 other locations | Recruiting | Feb 11, 2026 |
| Muscle Deterioration in Hospitalized Cancer Patients | — | Salamanca, Salamanca | Recruiting | Feb 4, 2026 |
| Metamizole (Optalgin) impact on anti‑Xa levels in cancer patients on apixaban or rivaroxaban | — | Haifa | Recruiting | Feb 3, 2026 |
| Financial burden for radiotherapy patients in Italy | — | Barletta and 6 other locations | Recruiting | Sep 16, 2025 |
All recruiting trials (5)
-
NUT Project: Nutritional Support in Thoracic Cancer
We’ll see if providing tailored nutrition guidance and assessment helps people with advanced lung cancer during their treatment.
-
My Care My Voice: helping patients and clinicians start palliative care conversations
This program tries to help oncologists, hospital staff, and adults with advanced cancer start timely palliative care conversations using brief materials and simple workflow changes in three Belgian hospitals.
-
Muscle Deterioration in Hospitalized Cancer Patients
A study test to see how muscle loss progresses in adults with cancer who are in the hospital and to help identify who might need muscle-support therapies.
-
Metamizole (Optalgin) impact on anti‑Xa levels in cancer patients on apixaban or rivaroxaban
This study will test whether taking metamizole (Optalgin) changes anti‑Xa blood levels in adults with cancer who are taking apixaban or rivaroxaban.
-
Financial burden for radiotherapy patients in Italy
This project will use a short Italian questionnaire to see if people getting radiotherapy in Italy face financial problems before, during, and after treatment.
Related topics
Quick answers
How many Oncologic Diseases clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (2 trials), Spain (1 trial), Israel (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.